Page last updated: 2024-10-17

2-aminoadipic acid and Cerebro-Hepato-Renal Syndrome

2-aminoadipic acid has been researched along with Cerebro-Hepato-Renal Syndrome in 1 studies

2-Aminoadipic Acid: A metabolite in the principal biochemical pathway of lysine. It antagonizes neuroexcitatory activity modulated by the glutamate receptor, N-METHYL-D-ASPARTATE; (NMDA).
2-aminoadipic acid : An alpha-amino acid that is adipic acid bearing a single amino substituent at position 2. An intermediate in the formation of lysine.

Research Excerpts

ExcerptRelevanceReference
"L-Pipecolic acid, a cyclic imino acid produced during the degradation of lysine, accumulates in body fluids of infants with the generalized peroxisomal disorders, including Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease."7.67Peroxisomal L-pipecolic acid oxidation is deficient in liver from Zellweger syndrome patients. ( Danks, DM; Mihalik, SJ; Moser, HW; Poulos, A; Rhead, WJ; Watkins, PA, 1989)
"L-Pipecolic acid, a cyclic imino acid produced during the degradation of lysine, accumulates in body fluids of infants with the generalized peroxisomal disorders, including Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease."3.67Peroxisomal L-pipecolic acid oxidation is deficient in liver from Zellweger syndrome patients. ( Danks, DM; Mihalik, SJ; Moser, HW; Poulos, A; Rhead, WJ; Watkins, PA, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mihalik, SJ1
Moser, HW1
Watkins, PA1
Danks, DM1
Poulos, A1
Rhead, WJ1

Other Studies

1 other study available for 2-aminoadipic acid and Cerebro-Hepato-Renal Syndrome

ArticleYear
Peroxisomal L-pipecolic acid oxidation is deficient in liver from Zellweger syndrome patients.
    Pediatric research, 1989, Volume: 25, Issue:5

    Topics: 2-Aminoadipic Acid; Adult; Child; Child, Preschool; Humans; Infant; Liver; Microbodies; Oxidation-Re

1989